Home › Funds › Citadel Advisors › TERN
Citadel Advisors position in TERN
TERNS PHARMACEUTICALS INC
Latest position (Q1 2026)3.75M sh
Reported value held$197.56M
Portfolio Weight0.03%
First reportedQ2 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 38.81K | $96.00K | New |
| Q4 2022 | 515.80K | $5.25M | New |
| Q1 2023 | 392.06K | $4.64M | Reduce |
| Q2 2023 | 46.66K | $408.24K | Reduce |
| Q3 2023 | 109.04K | $548.48K | Add |
| Q4 2023 | 64.64K | $419.51K | Reduce |
| Q1 2024 | 2.99M | $19.63M | Add |
| Q2 2024 | 1.55M | $10.55M | Reduce |
| Q3 2024 | 4.03M | $33.64M | Add |
| Q4 2024 | 3.54M | $19.62M | Reduce |
| Q1 2025 | 4.16M | $11.48M | Add |
| Q2 2025 | 3.99M | $14.88M | Reduce |
| Q3 2025 | 1.66M | $12.46M | Reduce |
| Q4 2025 | 3.40M | $137.39M | Add |
| Q1 2026 | 3.75M | $197.56M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TERN
- Vanguard Group 5.52M sh · $223.17M · Q4 2025
- Janus Henderson Group 1.47M sh · $77.51M · Q1 2026